Cargando…

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment

BACKGROUND: About 15 years ago, a diverse group of new recreational psychotropic substances began to emerge, which were marketed for example as “legal highs,” “research chemicals,” or “designer drugs.” These substances were later subsumed under the label “Novel Psychoactive Substances” (NPS). Import...

Descripción completa

Detalles Bibliográficos
Autores principales:	Specka, Michael, Kuhlmann, Thomas, Sawazki, Jürgen, Bonnet, Udo, Steinert, Renate, Cybulska-Rycicki, Monika, Eich, Helmut, Zeiske, Benita, Niedersteberg, Antje, Schaaf, Luzia, Scherbaum, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358402/ https://www.ncbi.nlm.nih.gov/pubmed/32733288 http://dx.doi.org/10.3389/fpsyt.2020.00569

Ejemplares similares

Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2021)

Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2022)

Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates
por: Bonnet, Udo, et al.
Publicado: (2022)

New Access Routes to Undertreated Populations; How Do Problem Substance Users Recruited from an Unemployment Office Differ from Detoxification Treatment Inpatients?
por: Scherbaum, Norbert, et al.
Publicado: (2021)

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
por: Bonnet, Udo, et al.
Publicado: (2020)

Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review
por: Bonnet, Udo, et al.
Publicado: (2022)

The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS
por: Wadsworth, Elle, et al.
Publicado: (2018)

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites
por: BIGDELI, Imanollah, et al.
Publicado: (2013)

Opiate maintenance patients’ attitudes and self-reported adherence to protective measures against SARS-CoV-2 infections
por: Specka, Michael, et al.
Publicado: (2023)

Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?
por: Florou, Dimitra, et al.
Publicado: (2021)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
por: Claus, Benedikt Bernd, et al.
Publicado: (2020)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon
por: Schifano, Fabrizio
Publicado: (2018)

Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps
por: Miliano, Cristina, et al.
Publicado: (2018)

Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects
por: Schifano, Fabrizio
Publicado: (2020)

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants
por: Miliano, Cristina, et al.
Publicado: (2016)

The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol
por: Khaled, Salma M., et al.
Publicado: (2016)

EDITORIAL: New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects
por: Pichini, Simona, et al.
Publicado: (2017)

Rapid Detection and Quantification of Novel Psychoactive Substances (NPS) Using Raman Spectroscopy and Surface-Enhanced Raman Scattering
por: Muhamadali, Howbeer, et al.
Publicado: (2019)

Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan
por: Yeh, Hsin-Tzu, et al.
Publicado: (2022)

Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter—In Silico and In Vitro Exploration of Dissociative Diarylethylamines
por: Sahai, Michelle A., et al.
Publicado: (2018)

The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP)
por: Loi, Barbara, et al.
Publicado: (2020)

Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project
por: Helander, Anders, et al.
Publicado: (2020)

Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
por: Giorgetti, Arianna, et al.
Publicado: (2021)

Establishment of Neurotoxicity Assessment Using Microelectrode Array (MEA) with hiPSC-Derived Neurons and Evaluation of New Psychoactive Substances (NPS)
por: Kang, Kyu-ree, et al.
Publicado: (2022)

Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
por: Scherbaum, Norbert, et al.
Publicado: (2021)

Analysis of Relationships between DAT1 Polymorphism Variants, Personality Dimensions, and Anxiety in New Psychoactive Substance (Designer Drug) (NPS) Users
por: Chmielowiec, Jolanta, et al.
Publicado: (2021)

Gabapentinoid-related deaths: An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?
por: Bonnet, Udo, et al.
Publicado: (2022)

Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries
por: Van Hout, Marie Claire, et al.
Publicado: (2017)

Corrigendum to ”HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances”
por: Mardal, Marie, et al.
Publicado: (2019)

New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017
por: Hondebrink, Laura, et al.
Publicado: (2020)

Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
por: Bonnet, Udo, et al.
Publicado: (2021)

Screening of new psychoactive substances (NPS) by gas-chromatography/time of flight mass spectrometry (GC/MS-TOF) and application to 63 cases of judicial seizure
por: Dei Cas, Michele, et al.
Publicado: (2019)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials
por: Vuilleumier, Caroline, et al.
Publicado: (2022)

Editorial: New Trends of Substance Abuse: Looking for New Psychotropic Effects of Chem Sex Drugs, Cognitive Enhancers, and New Psychoactive Substances
por: Pichini, Simona, et al.
Publicado: (2020)

Quality of Life in Patients with Substance Use Disorders Admitted to Detoxification Compared with Those Admitted to Hospitals for Medical Disorders: Follow-Up Results
por: Vederhus, John-Kåre, et al.
Publicado: (2016)

Psychoactive drugs and driving
por: Parekh, Vanita
Publicado: (2019)

Diagnostic capabilities of self-reported psychoactive substance use among patients admitted to psychiatric consultations in Benin, West Africa
por: Abdelhakim, Ahmat K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ojtu2bihh6sn3ep9qm7c4qshkp